Article citationsMore >>

Rice, Jessica, and Michelle Cameron. “Cannabinoids for Treatment of MS Symptoms: State of the Evidence.” Current Neurology and Neuroscience Reports, U.S. National Library of Medicine, 19 June 2018, www.ncbi.nlm.nih.gov/pubmed/29923025.

has been cited by the following article:

Article

Multiple Sclerosis Spastic Pain Relief Secondary to Medicinal Marijuana

1Touro College of Osteopathic Medicine, NY, New York, United States

2Holy Name Medical Center, Teaneck, NJ, United States


American Journal of Medical Case Reports. 2021, Vol. 9 No. 6, 339-341
DOI: 10.12691/ajmcr-9-6-9
Copyright © 2021 Science and Education Publishing

Cite this paper:
Eric J. Basile, Aaron Campeas, Omar Rafa, Autumn Breutzmann. Multiple Sclerosis Spastic Pain Relief Secondary to Medicinal Marijuana. American Journal of Medical Case Reports. 2021; 9(6):339-341. doi: 10.12691/ajmcr-9-6-9.

Correspondence to: Eric  J. Basile, Touro College of Osteopathic Medicine, NY, New York, United States. Email: Ebasile@student.touro.edu

Abstract

A 57-year-old male presented to an outpatient Multiple Sclerosis (MS) clinic for excruciating spastic pain secondary to MS. After a trial of multiple pain management drugs with no success, he began a trial of marijuana. In this paper, we report the extent of improvement in quality of life secondary to cannabinoid use after failing multimodal pain management regimens.

Keywords